1.

Record Nr.

UNINA9910792126203321

Autore

Lanzkowsky Philip <1932->

Titolo

Manual of pediatric hematology and oncology [[electronic resource] /] / Philip Lanzkowsky

Pubbl/distr/stampa

Amsterdam, : Elsevier/Academic Press, 2011

ISBN

1-282-87896-4

9786612878961

0-12-375155-1

Edizione

[5th ed.]

Descrizione fisica

1 online resource (1058 p.)

Disciplina

618.9215

Soggetti

Pediatric hematology

Tumors in children

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di bibliografia

Includes bibliographical references and index.

Nota di contenuto

Front Cover; Manual of Pediatric Hematology and Oncology; Copyright Page; Contents; Dedication; Contributors; Introduction; Preface to the Fifth Edition; Preface to the Fourth Edition; Preface to the Third Edition; Preface to the Second Edition; Preface to the First Edition; Chapter 1. Classification and Diagnosis of Anemia in Children; Chapter 2. Anemia During the Neonatal Period; Hemolytic Anemia; Failure of Red Cell Production; Anemia of Prematurity; Diagnostic Approach to Anemia in the Newborn; Chapter 3. Iron-Deficiency Anemia; Non-Hematological Manifestations; Staging; Treatment

Lymphoblastic LymphomaChapter 4. Megaloblastic Anemia; Special Treatment Considerations; Chapter 5. Hematologic Manifestations of Systemic Illness; Lead Intoxication; Nutritional Disorders; Bone Marrow Infiltration; Chapter 6. Bone Marrow Failure; Aplastic Anemia; Nephroblastomatosis; Congenital Dyserythropoietic Anemia (CDA); Sideroblastic Anemias (Mitochondrial Diseases with Bone Marrow Failure Syndromes); Chapter 7. Red Cell Membrane and Enzyme Defects; Neuroblastoma in the Neonate; Suggested Reading; Chapter 8. Hemoglobinopathies; Hemostasis in the Newborn; Unstable Hemoglobins

α-ThalassemiasSuggested Reading; Chapter 9. Extracorpuscular Hemolytic Anemia; Chapter 10. Polycythemia; Primary Familial and



Congenital Polycythemia; Suggested Reading; Chapter 11. Disorders of White Blood Cells; Decreased Polymorphonuclear Leukocyte Production; Clinical Features; Treatment; Increased Destruction or Disorders of Distribution of Polymorphonuclear Leukocytes; Neutrophil Production and Destruction in Newborn Infants; Suggested Reading; Chapter 12. Disorders of Platelets; Qualitative Platelet Disorders; Inherited Vascular and Connective Tissue Disorders

Laboratory Evaluation of Platelets and Platelet FunctionNonthrombocytopenic Purpura; Suggested Reading; Chapter 13. Hemostatic Disorders; Detection of Hemostatic Defects; Acquired Coagulation Factor Disorders; Chapter 14. Thrombotic Disorders; Thrombotic Disorders in Newborns; Sickle Cell Disease; Venous Thrombosis; Chapter 15. Lymphadenopathy and Splenomegaly; Lymphadenopathy; Suggested Reading; Suggested Reading; Chapter 16. Lymphoproliferative Disorders, Myelodysplastic Syndromes and Myeloproliferative Disorders; Suggested Reading; Chapter 17. Leukemias; Suggested Reading

Chapter 18. Histiocytosis SyndromesChapter 19. Hodgkin Lymphoma; Follow-up Evaluations; Suggested Reading; Chapter 20. Non-Hodgkin Lymphoma; Polycythemia in Childhood; Pathologic Classification; Diagnosis; Staging; Renal Cell Carcinoma (RCC); Chapter 21. Central Nervous System Malignancies; Diagnostic Evaluation; Survivorship; Astrocytomas; Brain Stem Tumors; Etiology; Chapter 22. Neuroblastoma; Pathology and Biology; Biology; Suggested Reading; Neuroblastoma in the Adolescent and Young Adult; Suggested Reading; Suggested Reading; Chapter 23. Renal Tumors; Diagnostic Evaluation

Suggested Reading

Sommario/riassunto

Given that there have been considerable advances in the treatment and management of oncologic diseases in children, the fifth edition of this successful clinical manual will be entirely updated to incorporate all current protocols and developments.This edition will be a comprehensive book on patient management, replete with algorithms and flow diagrams on diagnosis and management. Its concise and easy-to-read format will enable readers to make accurate diagnoses and permit them to treat patients without having extensive previous hematologic/oncologic experience. A list of normal values at v